Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 22:40:55 UTC
Update Date2021-09-26 23:17:32 UTC
HMDB IDHMDB0259779
Secondary Accession NumbersNone
Metabolite Identification
Common NameVemurafenib
DescriptionVemurafenib, also known as zelboraf, belongs to the class of organic compounds known as aryl-phenylketones. These are aromatic compounds containing a ketone substituted by one aryl group, and a phenyl group. Based on a literature review a significant number of articles have been published on Vemurafenib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Vemurafenib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Vemurafenib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
VemurafenibumChEBI
ZelborafChEBI
Chemical FormulaC23H18ClF2N3O3S
Average Molecular Weight489.922
Monoisotopic Molecular Weight489.072546264
IUPAC NameN-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide
Traditional Namevemurafenib
CAS Registry NumberNot Available
SMILES
CCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C1
InChI Identifier
InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)
InChI KeyGPXBXXGIAQBQNI-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aryl-phenylketones. These are aromatic compounds containing a ketone substituted by one aryl group, and a phenyl group.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbonyl compounds
Direct ParentAryl-phenylketones
Alternative Parents
Substituents
  • Aryl-phenylketone
  • 3-phenylpyridine
  • Sulfanilide
  • Pyrrolopyridine
  • Benzoyl
  • Halobenzene
  • Fluorobenzene
  • Chlorobenzene
  • Aryl chloride
  • Aryl halide
  • Benzenoid
  • Pyridine
  • Aryl fluoride
  • Organosulfonic acid amide
  • Organic sulfonic acid amide
  • Substituted pyrrole
  • Monocyclic benzene moiety
  • Heteroaromatic compound
  • Vinylogous amide
  • Vinylogous halide
  • Aminosulfonyl compound
  • Pyrrole
  • Sulfonyl
  • Organosulfonic acid or derivatives
  • Organic sulfonic acid or derivatives
  • Azacycle
  • Organoheterocyclic compound
  • Organofluoride
  • Organochloride
  • Organohalogen compound
  • Organic nitrogen compound
  • Organonitrogen compound
  • Organosulfur compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.95ALOGPS
logP4.62ChemAxon
logS-6.1ALOGPS
pKa (Strongest Acidic)7.17ChemAxon
pKa (Strongest Basic)3.2ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area91.92 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity121.97 m³·mol⁻¹ChemAxon
Polarizability48.1 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+211.91532859911
AllCCS[M+H-H2O]+209.71232859911
AllCCS[M+Na]+214.51232859911
AllCCS[M+NH4]+213.93532859911
AllCCS[M-H]-203.88832859911
AllCCS[M+Na-2H]-204.29432859911
AllCCS[M+HCOO]-204.90232859911
DeepCCS[M-2H]-241.63530932474
DeepCCS[M+Na]+217.0630932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
VemurafenibCCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C15638.6Standard polar33892256
VemurafenibCCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C14002.1Standard non polar33892256
VemurafenibCCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C14243.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Vemurafenib,1TMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C3892.4Semi standard non polar33892256
Vemurafenib,1TMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C3901.9Standard non polar33892256
Vemurafenib,1TMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C5153.9Standard polar33892256
Vemurafenib,1TMS,isomer #2CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F4004.9Semi standard non polar33892256
Vemurafenib,1TMS,isomer #2CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F3881.4Standard non polar33892256
Vemurafenib,1TMS,isomer #2CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F5120.7Standard polar33892256
Vemurafenib,2TMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C3840.0Semi standard non polar33892256
Vemurafenib,2TMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C4016.5Standard non polar33892256
Vemurafenib,2TMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C4849.6Standard polar33892256
Vemurafenib,1TBDMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C(C)(C)C4093.2Semi standard non polar33892256
Vemurafenib,1TBDMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C(C)(C)C4149.0Standard non polar33892256
Vemurafenib,1TBDMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C(C)(C)C5090.0Standard polar33892256
Vemurafenib,1TBDMS,isomer #2CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C(C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F4209.5Semi standard non polar33892256
Vemurafenib,1TBDMS,isomer #2CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C(C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F4090.5Standard non polar33892256
Vemurafenib,1TBDMS,isomer #2CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C(C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F5080.5Standard polar33892256
Vemurafenib,2TBDMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C(C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C(C)(C)C4228.4Semi standard non polar33892256
Vemurafenib,2TBDMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C(C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C(C)(C)C4476.3Standard non polar33892256
Vemurafenib,2TBDMS,isomer #1CCCS(=O)(=O)N(C1=CC=C(F)C(C(=O)C2=CN([Si](C)(C)C(C)(C)C)C3=NC=C(C4=CC=C(Cl)C=C4)C=C23)=C1F)[Si](C)(C)C(C)(C)C4829.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Vemurafenib GC-MS (Non-derivatized) - 70eV, Positivesplash10-054o-9212300000-fbdbb92088febd3eda6b2021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Vemurafenib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Vemurafenib , positive-QTOFsplash10-0006-0024900000-4911e6c7ad52fd2c28962017-09-14HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vemurafenib 10V, Positive-QTOFsplash10-0a4l-0281900000-e08321c7aa665a4f4c732017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vemurafenib 20V, Positive-QTOFsplash10-0a4l-6494400000-4ea2fc0a4cbd6d24d3ec2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vemurafenib 40V, Positive-QTOFsplash10-0a4i-1190000000-fd8302ac94aec0904dc42017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vemurafenib 10V, Negative-QTOFsplash10-000i-0020900000-de3f93933bd01bde416f2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vemurafenib 20V, Negative-QTOFsplash10-002k-0142900000-fa7a706c558c555f73152017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Vemurafenib 40V, Negative-QTOFsplash10-01t9-4980500000-02de2d40bd79e37e37f12017-07-26Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB08881
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID24747352
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkVemurafenib
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID63637
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]